open access

Vol 71, No 5 (2021)
Invited editorial
Published online: 2021-10-13
Get Citation

RECIST criteria and clinical practice

Piotr J. Wysocki1
DOI: 10.5603/NJO.2021.0060
·
Nowotwory. Journal of Oncology 2021;71(5):319-320.
Affiliations
  1. Oncology Chair and Clinic, Jagiellonian University, Collegium Medicum, Krakow, Poland

open access

Vol 71, No 5 (2021)
Invited editorial
Published online: 2021-10-13

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

RECIST criteria and clinical practice

Journal

Nowotwory. Journal of Oncology

Issue

Vol 71, No 5 (2021)

Article type

Invited editorial

Pages

319-320

Published online

2021-10-13

DOI

10.5603/NJO.2021.0060

Bibliographic record

Nowotwory. Journal of Oncology 2021;71(5):319-320.

Authors

Piotr J. Wysocki

References (5)
  1. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981; 47(1): 207–214, doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6.
  2. Therasse P, Arbuck S, Eisenhauer E, et al. New Guidelines to Evaluate the Response to Treatment in Solid Tumors. J Natl Cancer Inst. 2000; 92(3): 205–216.
  3. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009; 45(2): 228–247.
  4. Seymour L, Bogaerts J, Perrone A, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. The Lancet Oncology. 2017; 18(3): e143–e152.
  5. Płużański A. Evaluation of response to treatment — criteria RECIST 1.1. Nowotwory. Journal of Oncology. 2014; 64(4): 331–335.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl